THC Cross-Tolerance to Anandamide Differed Between Body Temperature and Isolated Tissue

THC pretreatment reduced anandamide sensitivity in isolated mouse tissue without producing detected cross-tolerance to anandamide-induced hypothermia. The same exposure history gave different answers depending on the endpoint.

The whole-animal comparison used temperature

After two days of THC pretreatment, mice showed tolerance to THC hypothermia and cross-tolerance to CP55,940 and WIN55,212-2 hypothermia. The same pretreatment did not produce detected cross-tolerance to anandamide's temperature effect. That exception is essential to the result.

The tissue comparison broadened the pattern

Vas deferens preparations from pretreated mice were less sensitive to inhibition of electrically evoked contractions by THC and all three challenge compounds, including anandamide. THC's concentration-response curve also showed reduced maximal inhibition. A curve shift and a lower response ceiling describe different aspects of adaptation.

The discrepancy remained a research question

The authors regarded the tissue preparation as useful for investigating pharmacodynamic tolerance but explicitly called for further work on the anandamide temperature exception. It would be inaccurate to present an established receptor explanation when the supplied material leaves the cause unresolved.

This experiment shows why a general statement about cross-tolerance needs the measured function attached. It does not demonstrate that anandamide is universally exempt from THC-related adaptation or that every tissue response predicts whole-animal behavior. Neither preparation establishes an individual's degree of cannabis impairment.

Related: interpreting cannabis tolerance claims.

Research cited

Pertwee RG; Stevenson LA; Griffin G. Cross-tolerance between delta-9-tetrahydrocannabinol and the cannabimimetic agents, CP 55,940, WIN 55,212-2 and anandamide. British journal of pharmacology (1993). doi:10.1111/j.1476-5381.1993.tb13989.x. Findings discussed from the study abstract.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

Acute THC Altered Adrenal Catecholamine Stores Without a Matching Enzyme Decline

An experimental THC study found lower adrenal-medullary catecholamine stores after acute exposure without a statistically significant decline in a key synthesis enzyme. The changes disappeared with repeated treatment, while circulating hormones followed partly different patterns. Tissue content and enzyme activity were separate measures Acute THC decreased adrenal norepinephrine and epinephrine…

Spread the love

Read Article: Acute THC Altered Adrenal Catecholamine Stores Without a Matching Enzyme Decline

Rimonabant Analogues Produced Cannabinoid-Like Mouse Behaviors Without THC-Like Drug Cues

Some experimental rimonabant analogues produced cannabinoid-like effects in mouse tests but did not reproduce THC's learned drug cue. Other comparisons also separated the compounds from THC, cautioning against equating a similar outward profile with the same pharmacology. Behavioral similarity was only the starting point O-6629 and O-6658 produced dose-dependent effects…

Spread the love

Read Article: Rimonabant Analogues Produced Cannabinoid-Like Mouse Behaviors Without THC-Like Drug Cues

Whole-Brain Receptor Assays Stayed Unchanged Despite Marked THC Behavioral Tolerance in Mice

A mouse study detected substantial THC behavioral tolerance without significant changes in whole-brain receptor binding or mRNA. The result limits a simple whole-brain explanation while leaving regional or functional changes unresolved. Behavior and biochemical assays were different endpoints Mice received THC twice daily for six and a half days. Testing…

Spread the love

Read Article: Whole-Brain Receptor Assays Stayed Unchanged Despite Marked THC Behavioral Tolerance in Mice

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us